Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Divi's Laboratories Limited
DIVISLABDivi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India. Address: Divi Towers, Hyderabad, India, 500032
Analytics
WallStreetin tavoitehinta
417 744.81 INRP/E-suhde
94.3456Osinkotuotto
0.51 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut DIVISLAB
Osinkoanalytiikka DIVISLAB
Osinkojen kasvu 5 vuoden aikana
200 %Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
32 %Osinkohistoria DIVISLAB
Osakkeen arvostus DIVISLAB
Talousasiat DIVISLAB
Tuloksia | 2019 | Dynamiikka |